| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $7,168,424 ) |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | P30HS029762 | Massachusetts Institute for Equity-Focused Learning Health System Science (MIELHSS) | 000 | 2 | AHRQ | 11/18/2024 | $997,446 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99NS140561 | Identification of a Circuit Basis for Neuropathic Pain in the Parabrachial Nucleus | 000 | 1 | NIH | 11/20/2024 | $124,713 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG082016 | Wake-sleep Circuitry in Neurodegenerative Dementias | 000 | 2 | NIH | 11/14/2024 | $777,303 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08HL161259 | Regulation of endothelial cell phosphatidylserine in thrombosis | 000 | 4 | NIH | 11/14/2024 | $165,024 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AI176120 | Development and Characterization of Phage QBeta-Based SARS-CoV-2 RT-qPCR Assay Calibration Standards | 000 | 2 | NIH | 11/6/2024 | $251,570 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG051658 | AD/ADRD and biological aging proteomic signatures in the etiopathology of delirium and its associated long-term cognitive decline | 001 | 7 | NIH | 11/26/2024 | $763,807 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL129506 | Privileged and primitive hematopoietic stem cells, niches, and regulatory T cells | 000 | 10 | NIH | 11/19/2024 | $696,709 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL171121 | Novel Role Of ACTN4 in Sodium Reabsorption and Salt-Sensitive Hypertension | 000 | 2 | NIH | 11/20/2024 | $631,041 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK130929 | Corticosteroids to Reduce Inflammation in Severe Pancreatitis (CRISP) | 000 | 4 | NIH | 11/27/2024 | $342,342 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG079864 | Brain Vulnerability in Delirium and Alzheimer’s Disease and Related Dementias: Intersection of Polygenic Risk and Inflammation | 000 | 3 | NIH | 11/26/2024 | $746,750 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AR062173 | The IL-23/IL-17 Axis in Inflammatory Arthritis | 000 | 10 | NIH | 11/27/2024 | $543,762 |
| | 2025 | 2025 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA276107 | Control of cancer cachexia via stimulation of resolution of inflammation | 000 | 2 | NIH | 11/25/2024 | $622,526 |
| | 2025 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UH3HL166785 | 1/2: PREcision VENTilation to attenuate Ventilation-Induced Lung Injury (PREVENT VILI) | 000 | 2 | NIH | 11/21/2024 | $0 |
| | 2025 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG065554 | Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients | 000 | 5 | NIH | 11/7/2024 | $0 |
| | 2025 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01GM148745 | Developing programmable RNA writing tools with the novel RNA-guided RNA-targeting CRISPR effector Cas7-11 | 001 | 2 | NIH | 11/14/2024 | $556,500 |
| | 2025 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HL150327 | DMGV and the AGXT2 pathway in chronic exercise-induced cardiometabolic adaptations. | 000 | 5 | NIH | 10/11/2024 | $0 |
| | 2025 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS120947 | Establishing a Brain Health Index | 000 | 3 | NIH | 10/11/2024 | $161,751 |
| | 2025 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA279550 | Mechanisms Promoting Copper Dependent Cell Death in Cancer | 001 | 2 | NIH | 11/25/2024 | $444,739 |
| | 2025 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01DK134806 | Investigating the regulation of distinct human adipocyte subpopulations | 000 | 2 | NIH | 11/26/2024 | $0 |
| | 2025 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL157530 | A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events | 000 | 4 | NIH | 11/26/2024 | $0 |
| | 2025 | 2024 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL161253 | Data-Driven Sleep Biomarkers of Brain Health, Heart Health, and Mortality | 002 | 4 | NIH | 12/5/2024 | $0 |
| | 2025 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK122976 | Leveraging the Rich Genetic Diversity of Vagal Motor Neurons to Decode Brain-to-Gut Communication | 000 | 5 | NIH | 11/18/2024 | -$2,941 |
| | 2025 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK089044 | Leptin, GABAergic Neurons and the Feedback / Feedforward Regulation of Energy Balance | 000 | 14 | NIH | 11/13/2024 | -$6,672 |
| | 2025 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AT012072 | Tai Chi Exercise and Wearable Feedback Technology to Promote Physical Activity in ACS Survivors | 000 | 2 | NIH | 10/29/2024 | $0 |
| | 2025 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99CA252044 | Therapeutic potential of FANCM for BRCA1-linked cancer | 000 | 2 | NIH | 10/10/2024 | -$84,134 |
| | 2025 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R35HL135775 | Thiol Isomerases in Hemostasis and Thrombosis | 000 | 7 | NIH | 10/9/2024 | -$1 |
| | 2025 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | T32HL007734 | Harvard Longwood Research Training in Vascular Surgery | 000 | 30 | NIH | 12/5/2024 | -$251,740 |
| | 2025 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL161253 | Data-Driven Sleep Biomarkers of Brain Health, Heart Health, and Mortality | 001 | 3 | NIH | 11/29/2024 | $0 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99CA263194 | Novel regulation of the CDK4/Cdh1/Pin1 signaling axis for targeted breast cancer therapies | 000 | 2 | NIH | 11/19/2024 | $0 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U01AA026977 | Alcoholic Hepatitis Clinical and Translational Network Late Phase Clinical Trials and Observational Studies 4/9 | 000 | 6 | NIH | 11/7/2024 | $0 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U01AA026933 | Biomarkers of Disease in Alcoholic Hepatitis | 000 | 6 | NIH | 11/15/2024 | $0 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK097441 | Molecular Control of Brown Adipose Cell Fate and Energy Metabolism | 000 | 11 | NIH | 11/13/2024 | -$13,237 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK112886 | Thiamine as Adjunctive Therapy for Diabetic Ketoacidosis | 000 | 5 | NIH | 11/13/2024 | -$5,099 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HS026215 | Characterizing Opioid-related Adverse Events in Older Adults After Hospital Discharge | 000 | 5 | AHRQ | 11/14/2024 | $0 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21AG065923 | PGC-1α, Purines and the Postmenopausal Heart | 000 | 2 | NIH | 11/5/2024 | -$2 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS078263 | MECHANISMS OF CSD-EVOKED PERSISTENT ACTIVATION OF MENINGEAL NOCICEPTORS | 000 | 9 | NIH | 10/15/2024 | -$1 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA212649 | Personalized vaccine for patients with AML | 000 | 6 | NIH | 10/11/2024 | $0 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23HD088695 | Longitudinal trajectories of early childhood respiratory symptomatology and their impact on behavioral development | 000 | 5 | NIH | 11/19/2024 | -$16,428 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21NS130561 | Meningeal Nociceptor-Immune Signaling in Migraine | 000 | 1 | NIH | 11/29/2024 | $0 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R03DK129637 | Phosphorylation of the podocyte cytoskeleton in diabetic nephropathy | 000 | 2 | NIH | 12/4/2024 | -$50,686 |
| | 2025 | 2022 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL161253 | Data-Driven Sleep Biomarkers of Brain Health, Heart Health, and Mortality | 000 | 2 | NIH | 11/22/2024 | $0 |
| | 2025 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21DA051813 | Cocaine induces production of infectious large extracellular vesicles (lEV) and regulates neuro-inflammation | 000 | 2 | NIH | 11/13/2024 | -$45,536 |
| | 2025 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01ES028688 | Maternal organophosphate pesticide exposure, low birth weight and placental injury | 000 | 4 | NIH | 11/12/2024 | -$12,553 |
| | 2025 | 2021 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | RF1NS120947 | Establishing a Brain Health Index | 000 | 2 | NIH | 10/11/2024 | -$161,751 |
| | 2025 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21CA251992 | Proteomic Characterization of Genomically Complex Sarcomas | 004 | 2 | NIH | 11/6/2024 | $0 |
| | 2025 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21CA251992 | Proteomic Characterization of Genomically Complex Sarcomas | 003 | 2 | NIH | 11/5/2024 | -$386 |
| | 2025 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21CA251992 | Proteomic Characterization of Genomically Complex Sarcomas | 002 | 2 | NIH | 11/5/2024 | $386 |
| | 2025 | 2020 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21NS118434 | Electrical impedance tomography for the improved assessment of pulmonary function in neuromuscular disease | 000 | 1 | NIH | 11/1/2024 | -$1,849 |
| | 2025 | 2018 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG051658 | AD/ADRD and biological aging proteomic signatures in the etiopathology of delirium and its associated long-term cognitive decline | 000 | 3 | NIH | 10/1/2024 | -$4,928 |
|
|
